1. Home
  2. MD vs HROW Comparison

MD vs HROW Comparison

Compare MD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MD
  • HROW
  • Stock Information
  • Founded
  • MD 1979
  • HROW 1998
  • Country
  • MD United States
  • HROW United States
  • Employees
  • MD N/A
  • HROW N/A
  • Industry
  • MD Hospital/Nursing Management
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MD Health Care
  • HROW Health Care
  • Exchange
  • MD Nasdaq
  • HROW Nasdaq
  • Market Cap
  • MD 1.4B
  • HROW 1.4B
  • IPO Year
  • MD 1995
  • HROW N/A
  • Fundamental
  • Price
  • MD $17.39
  • HROW $37.56
  • Analyst Decision
  • MD Buy
  • HROW Strong Buy
  • Analyst Count
  • MD 7
  • HROW 7
  • Target Price
  • MD $16.79
  • HROW $68.50
  • AVG Volume (30 Days)
  • MD 721.7K
  • HROW 801.9K
  • Earning Date
  • MD 11-03-2025
  • HROW 11-10-2025
  • Dividend Yield
  • MD N/A
  • HROW N/A
  • EPS Growth
  • MD N/A
  • HROW N/A
  • EPS
  • MD 1.29
  • HROW N/A
  • Revenue
  • MD $1,940,725,000.00
  • HROW $227,661,000.00
  • Revenue This Year
  • MD N/A
  • HROW $43.92
  • Revenue Next Year
  • MD $2.73
  • HROW $41.22
  • P/E Ratio
  • MD $13.44
  • HROW N/A
  • Revenue Growth
  • MD N/A
  • HROW 47.69
  • 52 Week Low
  • MD $11.84
  • HROW $20.85
  • 52 Week High
  • MD $18.22
  • HROW $54.19
  • Technical
  • Relative Strength Index (RSI)
  • MD 56.45
  • HROW 41.10
  • Support Level
  • MD $17.34
  • HROW $36.20
  • Resistance Level
  • MD $18.11
  • HROW $39.77
  • Average True Range (ATR)
  • MD 0.44
  • HROW 1.93
  • MACD
  • MD 0.09
  • HROW -0.35
  • Stochastic Oscillator
  • MD 68.56
  • HROW 22.26

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: